ArticleJournal of acquired immune deficiency syndromes (1999)2009

Tonsillar application of AT-2 SIV affords partial protection against rectal challenge with SIVmac239.

Panagiotis Vagenas et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.